# Study of ZGGS18 in Combination With ZG005 in Patients With Advanced Solid Tumors

> **NCT06938880** · PHASE1,PHASE2 · RECRUITING · sponsor: **Suzhou Zelgen Biopharmaceuticals Co.,Ltd** · enrollment: 60 (estimated)

## Conditions studied

- Advanced Solid Tumor

## Interventions

- **BIOLOGICAL:** ZGGS18 for Injection
- **BIOLOGICAL:** ZG005 for Injection

## Key facts

- **NCT ID:** NCT06938880
- **Lead sponsor:** Suzhou Zelgen Biopharmaceuticals Co.,Ltd
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-05-20
- **Primary completion:** 2027-05
- **Final completion:** 2028-04
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2026-01-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06938880

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06938880, "Study of ZGGS18 in Combination With ZG005 in Patients With Advanced Solid Tumors". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT06938880. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*